Prothrombin complex concentrates: Difference between revisions
Kghaffarian (talk | contribs) (created PCC page) |
|||
Line 47: | Line 47: | ||
==See Also== | ==See Also== | ||
*[[Blood transfusions]] | |||
==Sources== | ==Sources== |
Revision as of 17:54, 28 May 2015
General
- Type: Hemostatics, blood components
- Dosage Forms:lypophilized concentrate for reconstitution 500u/vial and 1000u/vial
- Common Trade Names: Kcentra
Adult Dosing
- Based on pretreatment INR, units based on factor 9 content
- INR2-<4: 25units/kg, not to exceed 2500 units
- INR4-<6: 35units/kg, not to exceed 3500 units
- INR>6: 50units/kg, not to exceed 5000 units
Pediatric Dosing
Safety and efficacy not established
Special Populations
- Pregnancy Rating: C
- Lactation: Unknown, breast feeding not advised
- Renal Dosing
- Adult-N/A
- Pediatric-N/A
- Hepatic Dosing
- Adult-N/A
- Pediatric-N/A
Contraindications
- Allergy to class/drug
- DIC
- known HIT (Heparin induced thrombocytopenia)
Serious
- thromboembolism
- blood product (hepatitis, HIV)
Common
- thromboembolic events (8.7%)
- headache (7.8%)
- hypotension (4.9%)
- nausea/vomiting
- arthralgia
- ICH (2.9%)
- mental status change (2.9%)
- hypertension (2.9%)
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
See Also
Sources
Medscape